Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease. Quan J, Markovinovic A, Hracs L, Ma C, et al. Lancet Gastroenterol Hepatol 2023 Oct 6:S2468-1253(23)00310.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Quan J, Markovinovic A, Hracs L, Ma C, et al. Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease. Lancet Gastroenterol Hepatol 2023 Oct 6:S2468-1253(23)00310.
PMID: 37813111